| DRUG WATCH |
|
| Year : 2021 | Volume
: 53
| Issue : 4 | Page : 298-300 |
Moxifloxacin-induced oral erythema multiforme: An unusual adverse effect hitherto unreported
Somnath Das, Olympia Rudra, Surabhi Sharma, Subhadeep Mallick
Department of Dermatology, IPGME and R and SSKM Hospital, Kolkata, West Bengal, India
Correspondence Address:
Dr. Olympia Rudra
Department of Dermatology, IPGME and R and SSSKM Hospital, Kolkata - 700 020, West Bengal
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/ijp.ijp_771_19
Moxifloxacin is a fluoroquinolone with excellent activity in community-acquired respiratory tract infections. Common adverse effects are gastrointestinal symptoms, headache, dizziness, etc., Some serious adverse effects include tendon rupture, rhabdomyolysis, peripheral neuropathy, and interstitial nephritis. Cutaneous adverse effects include allergic reactions, angioedema, Steven–Johnson syndrome, and toxic epidermal necrosis. Erythema multiforme (EM), an acute self-limiting disease, most commonly occurs due to infection and rarely due to drugs or systemic disease. EM is classified into EM major and minor, both having skin lesions. A third category of EM has also been described with only oral involvement and without any skin lesions. Oral EM itself is an uncommon entity which has been reported due to nonsteroidal anti-inflammatory drugs. Here, we are reporting a case of moxifloxacin-induced oral EM. After extensive search in PubMed-Medline database, we could not find any such co-occurrence of moxifloxacin-induced oral EM. To the best of our knowledge, this is the first reported case.
[FULL TEXT] [PDF]*
|
